Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Trop Med Int Health ; 16(7): 863-8, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21481106

RESUMEN

OBJECTIVES: To evaluate oral poliovirus vaccine (OPV) coverage of the November 2009 round in five Northern Nigeria states with ongoing wild poliovirus transmission using clustered lot quality assurance sampling (CLQAS). METHODS: We selected four local government areas in each pre-selected state and sampled six clusters of 10 children in each Local Government Area, defined as the lot area. We used three decision thresholds to classify OPV coverage: 75-90%, 55-70% and 35-50%. A full lot was completed, but we also assessed in retrospect the potential time-saving benefits of stopping sampling when a lot had been classified. RESULTS: We accepted two local government areas (LGAs) with vaccination coverage above 75%. Of the remaining 18 rejected LGAs, 11 also failed to reach 70% coverage, of which four also failed to reach 50%. The average time taken to complete a lot was 10 h. By stopping sampling when a decision was reached, we could have classified lots in 5.3, 7.7 and 7.3 h on average at the 90%, 70% and 50% coverage targets, respectively. CONCLUSIONS: Clustered lot quality assurance sampling was feasible and useful to estimate OPV coverage in Northern Nigeria. The multi-threshold approach provided useful information on the variation of IPD vaccination coverage. CLQAS is a very timely tool, allowing corrective actions to be directly taken in insufficiently covered areas.


Asunto(s)
Muestreo para la Garantía de la Calidad de Lotes , Vacuna Antipolio Oral/administración & dosificación , Vacunación/estadística & datos numéricos , Preescolar , Análisis por Conglomerados , Femenino , Humanos , Programas de Inmunización , Lactante , Muestreo para la Garantía de la Calidad de Lotes/métodos , Masculino , Nigeria , Garantía de la Calidad de Atención de Salud , Vacunación/normas
2.
J Pediatr ; 135(6): 683-8, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10586169

RESUMEN

OBJECTIVE: To determine the frequency of later respiratory tract morbidity after respiratory syncytial virus (RSV) disease in infancy. DESIGN: Cohort study with passive, clinic-based surveillance. SETTING: Outpatient department in The Gambia. SUBJECTS: One hundred five children admitted to the hospital with severe RSV disease (case cohort), 105 control children matched for age not admitted to the hospital during the previous RSV season (control cohort 1), and 102 control children born after the RSV season (control cohort 2). MAIN OUTCOME MEASURES: Frequencies of pneumonia, wheezing, and hospital admission with acute lower respiratory tract infection. RESULTS: Pneumonia was more common in case children than in both control groups (adjusted incidence rate ratio [IRR, 95% CI]: 3.80 [2.73, 6. 10]), as was wheezing (IRR 7.33 [3.10,17.54]), pneumonia or wheezing (IRR 3.96 [2.60, 6.04]), and admission with pneumonia or wheezing (IRR 3.40 [1.87, 6.15]). The incidence rate per 100 child-years for pneumonia in the dry season for 12-month-old children was 27 for case patients, 8.1 for control cohort 1, and 6.51 for control cohort 2. By 3 years of age, the rates had fallen to low levels in all groups. CONCLUSIONS: Pneumonia and wheezing are significantly more common in children after RSV-associated lower respiratory tract disease than in control subjects, but the incidence declines rapidly with increasing age.


Asunto(s)
Infecciones por Virus Sincitial Respiratorio/complicaciones , Enfermedades Respiratorias/etiología , Enfermedad Aguda , Asma/etiología , Preescolar , Estudios de Cohortes , Gambia , Humanos , Vigilancia de la Población , Estaciones del Año
3.
J Cardiovasc Pharmacol ; 33(4): 567-72, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10218726

RESUMEN

We studied the endothelin receptors mediating contraction in the human saphenous vein (SV) and internal thoracic artery (ITA). In the SV, the ET(A)-receptor antagonist BQ123 (1 microM) did not significantly shift the ET-1 concentration-response curve but did cause a parallel shift in the ITA. In the SV, the ET(A)-receptor agonist sarafotoxin 6b (S6b) produced a monophasic concentration-response curve that was antagonised biphasically by BQ123 (0.1-1 microM). In the ITA, S6b was an ineffective agonist with contractions seen only at 3 x 10(-9) M upward. The ET(B)-receptor agonist sarafotoxin 6c (S6c) caused constrictions in only 74% of SV rings and 42% of ITA rings. In the tissues that did respond, S6c caused a monophasic concentration-response curve with a lower maximal response than ET-1. The ET(B) antagonist BQ788 did not antagonise the responses to ET-1 in either the SV or the ITA but did antagonise the responses to S6c in the SV. The results from this study suggest that mainly ET(A) receptors mediate the contractile responses in the human SV and ITA. There is also evidence for an ET(B)-mediated response, although the contractions were much smaller than those elicited by ET-1. We also conclude that the ET(A) receptors mediating responses in these human vessels are atypical because of the different effects of BQ123 on the two vessels.


Asunto(s)
Arterias Mamarias/metabolismo , Receptores de Endotelina/metabolismo , Vena Safena/metabolismo , Adulto , Anciano , Antagonistas de los Receptores de Endotelina , Endotelina-1/farmacología , Humanos , Arterias Mamarias/efectos de los fármacos , Arterias Mamarias/fisiología , Persona de Mediana Edad , Péptidos Cíclicos/farmacología , Receptor de Endotelina B , Vena Safena/efectos de los fármacos , Vena Safena/fisiología , Vasoconstricción/efectos de los fármacos
4.
J Cardiovasc Pharmacol ; 31 Suppl 1: S172-4, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9595430

RESUMEN

At present, endothelin (ET) receptor classification remains controversial. We investigated the presence of atypical ETA receptors in human saphenous veins (SV). Human SV was obtained from 24 patients undergoing coronary artery bypass grafting. Vessels were set up in organ baths, stretched to a tension of 6 g, and left to relax before being challenged with 90 mM KCl. After KCl challenge, tissues were incubated with 2.8 microM indomethacin and 100 microM L-NMMA for 30 min followed by 30 min in the presence of antagonist before a concentration-response curve to ET-1 or sarafotoxin 6b (S6b) (10(-10)-10(-7) M) was constructed. In endothelium-intact vessels, incubated with indomethacin and L-NMMA, BQ-123 (1 microM) caused nonparallel shifts, with lower concentrations of ET-1 being antagonized more than higher concentrations. This antagonism with BQ-123 was unaffected by BQ-788 (0.1 microM; n = 6) or by desensitization of ETB receptors with S6c (0.1 microM; n = 8). Blocking the Ca2+ channels with nifedipine (1 microM; n = 5) did not affect the antagonism, nor did denuding the endothelium or leaving the endothelium intact (n = 5). When S6b was used as an agonist, BQ-123 (0.3-3 microM) caused concentration-dependent biphasic shifts, with low concentrations of S6b not being antagonized. In conclusion, the antagonism observed with BQ-123 is not due to the action of ET-1 at ETB receptors, changes in Ca2+ handling, or endothelium. This unusual action of BQ-123 suggests subtypes of the ETA receptor.


Asunto(s)
Antagonistas de los Receptores de Endotelina , Músculo Liso Vascular/efectos de los fármacos , Péptidos Cíclicos/farmacología , Vena Safena/efectos de los fármacos , Adulto , Anciano , Humanos , Técnicas In Vitro , Persona de Mediana Edad , Contracción Muscular/efectos de los fármacos , Oligopéptidos/farmacología , Piperidinas/farmacología , Receptor de Endotelina A , Receptor de Endotelina B , Vasoconstrictores/farmacología , Venenos de Víboras/farmacología
6.
Ann Intern Med ; 124(1 Pt 1): 69, 1996 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-7503482
8.
Opt Lett ; 12(10): 784-6, 1987 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-19741871

RESUMEN

A novel noninverting optoelectronic logic device using a GaAs/AlGaAs multiple-quantum-well modulator is demonstrated that combines electronic nonlinearity with optical input and output and is bistable. The device is bistable but displays hard limiting and an optical gain of 12.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA